{"id":"https://openalex.org/W4384070751","doi":"https://doi.org/10.1158/1541-7786.c.6738488.v1","title":"Data from Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination\u2013Deficient Leukemia Cells","display_name":"Data from Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination\u2013Deficient Leukemia Cells","publication_year":2023,"publication_date":"2023-07-12","ids":{"openalex":"https://openalex.org/W4384070751","doi":"https://doi.org/10.1158/1541-7786.c.6738488.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.c.6738488.v1","doi":"https://doi.org/10.1158/1541-7786.c.6738488.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6738488.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1541-7786.c.6738488.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019831669","display_name":"Katherine Sullivan-Reed","orcid":"https://orcid.org/0000-0001-9585-7848","observed_orcids":["https://orcid.org/0000-0001-9585-7848"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine Sullivan-Reed","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9585-7848","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038292704","display_name":"Monika Maria Toma","orcid":"https://orcid.org/0000-0001-8414-253X","observed_orcids":["https://orcid.org/0000-0001-8414-253X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monika M. Toma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8414-253X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025976446","display_name":"Ma\u0142gorzata Drzewiecka","orcid":"https://orcid.org/0000-0002-5869-7993","observed_orcids":["https://orcid.org/0000-0002-5869-7993"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malgorzata Drzewiecka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5869-7993","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049450086","display_name":"Margaret Nieborowska-Skorska","orcid":"https://orcid.org/0009-0002-7798-1575","observed_orcids":["https://orcid.org/0009-0002-7798-1575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret Nieborowska-Skorska","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-7798-1575","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054895103","display_name":"Reza Nejati","orcid":"https://orcid.org/0000-0002-2188-156X","observed_orcids":["https://orcid.org/0000-0002-2188-156X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reza Nejati","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2188-156X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073852871","display_name":"Adam Karami","orcid":"https://orcid.org/0009-0009-1448-9955","observed_orcids":["https://orcid.org/0009-0009-1448-9955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Karami","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-1448-9955","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062887811","display_name":"Mariusz A. Wasik","orcid":"https://orcid.org/0000-0002-1988-3670","observed_orcids":["https://orcid.org/0000-0002-1988-3670"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariusz A. Wasik","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1988-3670","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066651403","display_name":"Tomasz \u015aliwi\u0144ski","orcid":"https://orcid.org/0000-0001-8385-7744","observed_orcids":["https://orcid.org/0000-0001-8385-7744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomasz Sliwinski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8385-7744","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063022331","display_name":"Tomasz Sk\u00f3rski","orcid":"https://orcid.org/0000-0002-3809-4538","observed_orcids":["https://orcid.org/0000-0002-3809-4538"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomasz Skorski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3809-4538","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.5913000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.5913000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.4016000032424927,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-polymerase-theta","display_name":"DNA polymerase theta","score":0.9950000047683716},{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.8930000066757202},{"id":"https://openalex.org/keywords/rad52","display_name":"RAD52","score":0.9990000128746033},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9700000286102295},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9929999709129333},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.8479999899864197},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.8830000162124634},{"id":"https://openalex.org/keywords/end-joining","display_name":"end-joining","score":0.7760000228881836},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/aml1-eto","display_name":"AML1-ETO","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9100000262260437},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8320000171661377},{"id":"https://openalex.org/keywords/brca1-2-deficiency","display_name":"BRCA1/2 deficiency","score":0.9049999713897705}],"concepts":[{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.658932089805603},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6445192694664001},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.6306600570678711},{"id":"https://openalex.org/C2756471","wikidata":"https://www.wikidata.org/wiki/Q206286","display_name":"DNA polymerase","level":3,"score":0.5851712822914124},{"id":"https://openalex.org/C2776630724","wikidata":"https://www.wikidata.org/wiki/Q18031020","display_name":"RAD52","level":5,"score":0.49539387226104736},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48564162850379944},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.4705308675765991},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.45108872652053833},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.4421403408050537},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4008098244667053},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3405854403972626},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.3023607134819031},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.22309282422065735},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.17978918552398682}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1541-7786.c.6738488.v1","doi":"https://doi.org/10.1158/1541-7786.c.6738488.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6738488.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.c.6738488.v1","doi":"https://doi.org/10.1158/1541-7786.c.6738488.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6738488.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9074000120162964,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6299999952316284,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4382010766","https://openalex.org/W4401455145","https://openalex.org/W4283276365","https://openalex.org/W4391987261","https://openalex.org/W3169893021","https://openalex.org/W4362593130","https://openalex.org/W4310160990","https://openalex.org/W4393096467","https://openalex.org/W4389140163","https://openalex.org/W6965443026"],"abstract_inverted_index":{"Abstract":[0],"DNA":[1,18],"polymerase":[2],"theta":[3],"(Pol\u03b8,":[4],"encoded":[5],"by":[6,40],"POLQ":[7],"gene)":[8],"plays":[9],"an":[10],"essential":[11],"role":[12],"in":[13,28,67,84],"Pol\u03b8-mediated":[14],"end-joining":[15],"(TMEJ)":[16],"of":[17,23,56,73,99,103,117,143],"double-strand":[19],"breaks":[20],"(DSB).":[21],"Inhibition":[22],"Pol\u03b8":[24,57,104],"is":[25],"synthetic":[26,64],"lethal":[27,65],"homologous":[29],"recombination":[30],"(HR)-deficient":[31],"tumor":[32],"cells.":[33,70,129],"However,":[34],"DSBs":[35,118],"can":[36],"be":[37],"also":[38],"repaired":[39],"PARP1":[41,59],"and":[42,58,79,86,119,126],"RAD52-mediated":[43],"mechanisms.":[44],"Because":[45],"leukemia":[46,69,125],"cells":[47,88],"accumulate":[48],"spontaneous":[49],"DSBs,":[50],"we":[51,133],"tested":[52],"if":[53],"simultaneous":[54],"targeting":[55],"or":[60,110,137],"RAD52":[61,111],"enhance":[62],"the":[63,74],"effect":[66,122,142],"HR-deficient":[68,124,146],"Transformation":[71],"potential":[72],"oncogenes":[75],"inducing":[76],"BRCA1/2-deficiency":[77],"(BCR-ABL1":[78],"AML1-ETO)":[80],"was":[81,95],"severely":[82],"limited":[83],"Polq\u2212/\u2212;Parp1\u2212/\u2212":[85],"Polq\u2212/\u2212;Rad52\u2212/\u2212":[87],"when":[89,106],"compared":[90],"with":[91,97,108],"single":[92],"knockouts,":[93],"which":[94],"associated":[96],"accumulation":[98,116],"DSBs.":[100],"Small-molecule":[101],"inhibitor":[102],"(Pol\u03b8i)":[105],"combined":[107],"PARP":[109],"inhibitors":[112],"(PARPi,":[113],"RAD52i)":[114],"caused":[115],"exerted":[120],"increased":[121],"against":[123,145],"myeloproliferative":[127],"neoplasm":[128],"Implications:":[130],"In":[131],"conclusion,":[132],"show":[134],"that":[135],"PARPi":[136],"RAD52i":[138],"might":[139],"improve":[140],"therapeutic":[141],"Pol\u03b8i":[144],"leukemias.":[147]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-07-13T00:00:00"}